Posterity Fertility, P.C.

Posterity Health, Inc. is a US-based healthcare company specializing in men's health solutions, particularly fertility and hormone optimization, through tailored services and innovative treatments. Founded in 2021 and headquartered in Centennial, Colorado, Posterity Health, Inc. focuses on providing comprehensive reproductive health services for men.

The company has successfully completed 4 funding deals with its most recent being a Series A round of USD 12. 832 mn on January 10, 2025, led by Georgetown Equity Partners. The total capital raised by the firm is USD 12. 832 mn, with a current valuation of USD 55.

098 mn. The company was founded by individuals who have not been publicly identified, and it does not have any known subsidiaries or parent companies. Posterity Health specializes in men’s health solutions, focusing on fertility and hormone optimization through various offerings. Their primary services include a comprehensive Male Fertility Workup, which evaluates reproductive health beyond sperm count, and targeted treatments for low testosterone.

These services are facilitated by a team of fellowship-trained reproductive urologists who provide personalized care through virtual consultations and in-person visits. The company also offers Posterity+, an all-in-one fertility supplement aimed at improving sperm health, alongside vasectomy and vasectomy reversal services. Posterity Health operates across all 50 states in the U. S.

, partnering with major health insurers and fertility benefit managers to ensure coverage for many of its services, thus reaching a diverse client base that includes individuals seeking to enhance their fertility and overall reproductive health. Posterity Health generates revenue through a model that integrates insurance coverage for its clinical services, allowing for direct reimbursement from major providers such as United Healthcare and Aetna. Transactions typically occur on a fee-for-service basis, where clients seek consultations or treatment plans that may involve diagnostic testing and follow-up care. The company's flagship offerings, including the Male Fertility Workup and testosterone therapy, are structured to provide individualized health plans, ensuring clients pay only for the services rendered.

Additionally, the integration of fertility benefit managers into their business model creates a streamlined process for clients, minimizing out-of-pocket expenses and enhancing access to necessary services, thereby facilitating a consistent revenue flow from both individual and partnered healthcare arrangements. In January 2025, Posterity Health, Inc. raised USD 12. 83 million in Series A funding led by new investor Georgetown Equity Partners, with participation from other new investors Scrub Capital and SteelSky Ventures alongside returning investors Distributed Ventures, FCA Venture Partners, WVV Capital, and others.

The company plans to utilize this funding to expand its platform and increase its reach, providing reproductive care to men at all stages of life. Specific details about upcoming products have not been disclosed, but the company is targeting geographical expansion to enhance its market presence.